BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 18, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 19, 2011
View Archived Issues
New agents target pathways involved in antipsychotic drug response
Read More
New candidate immunotherapies for ovarian cancer developed in Japan
Read More
Results presented from pilot study of Panvac vaccine
Read More
First-in-class mitotic kinase inhibitor shows anticancer properties
Read More
New antimicrobials show promise to treat urinary tract infections
Read More
Vertex patents new ATR inhibitors for cancer
Read More
BioSante Pharmaceuticals reports new phase III LibiGel data
Read More
Endocyte's PRECEDENT trial results confirmed by supplemental analyses
Read More
FDA grants orphan drug status to Pinnacle Biologics product
Read More
Novel PRCP inhibitors discovered at Merck & Co.
Read More
Array BioPharma patents new GPR119 receptor agonists
Read More
Takeda synthesizes novel TGFR-1 inhibitors
Read More
Merck & Co. reports new antihypertensive drugs
Read More
Gilead Sciences claims new antiviral products
Read More
NeuroSearch's SK channel research passed to new spin-out
Read More
Novartis Pharma stops clinical development of SMC-021
Read More
Treatment begins in phase III Benlysta trial
Read More
Trillium set to begin phase I TTI-1612 trial in Canada
Read More
Novartis' third phase III Gilenya study confirms previous encouraging outcomes
Read More
Soligenix begins to develop next-generation anthrax vaccine
Read More
AtheroNova plans IND submission for AHRO-001
Read More
FDA sets action date for Dymista NDA
Read More
Isis Pharmaceuticals provides update on NDA submission for mipomersen sodium
Read More
Prana Biotechnology begins recruitment in phase II PBT-2 trial
Read More
Hybrigenics completes enrollment in phase II inecalcitol trial
Read More